Skip to main content
Premium Trial:

Request an Annual Quote

Where Are They Now?: Oct 1, 2003

Premium

Genome Technology’s October 2002 issue was the annual All-Stars edition announcing the winners of the second annual GT All-Stars competition. Last year’s winners — Ruedi Aebersold, Howard Cash, Stephen Fodor, Jim Kent, Martin Leach, Elaine Mardis, Jonathan Rothberg, and Shankar Subramaniam, as well as Affymetrix for company of the year and PerkinElmer’s AcycloPrime as product of the year — have continued to make headlines. Mardis, for instance, was on hand at the NIH earlier this year to help celebrate the completed genome, and Cash still regularly jets from his Michigan office to New York for work on the DNA identification of victims of September 11.

The 2003 GT All-Stars will be featured in the November issue of the magazine. Watch for it in your mailbox next month.

Another article in last year’s magazine looked at Amersham’s CodeLink acquisition and asked whether that would enable the British company to compete with Affymetrix. In this issue, you’ll see that neither of these companies surpassed Applied Biosystems or Agilent in release plans for a single chip containing the entire human genome (see p. 24).

Also appearing last year was the news that Peter Coggins had started at PerkinElmer after leaving Amersham. In the February ’03 issue of Genome Technology, Coggins revealed his plans for the life and analytical sciences unit he heads up — including a new service model where PerkinElmer engineers will provide maintenance for customers’ instruments, even those made by other companies.

 

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.